1262036-50-9

1262036-50-9 structure

Name: LY2886721
Chemical Name: N-[3-[(4aS,7aS)-2-amino-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide
CAS Number: 1262036-50-9
Molecular Formula: C₁₈H₁₆F₂N₄O₂S
Molecular Weight: 390.407
Catalog: Biochemical Inhibitor Neuronal Signaling BACE inhibitor
Create Date: 2017-08-29 06:08:07
Modify Date: 2024-01-02 15:50:20
LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.IC50 value:Target: BACELY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments. LY2886721 is under clinical study. A Safety Study of LY2886721 Multiple Doses is performing in Healthy Subjects.

Name	N-[3-[(4aS,7aS)-2-amino-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide
Synonyms	LY-2886721 cc-426 S2156_Selleck UNII:2CQ62IWB67 LY2886721 UNII-2CQ62IWB67 LY 2886721

Description	LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.IC50 value:Target: BACELY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments. LY2886721 is under clinical study. A Safety Study of LY2886721 Multiple Doses is performing in Healthy Subjects.
Related Catalog	Signaling Pathways >> Neuronal Signaling >> Beta-secretase Research Areas >> Neurological Disease
References	[1]. A Safety Study of LY2886721 Multiple Doses in Healthy Subjects

Hazard Codes	Xi

1262037-71-7

~99%

1262036-50-9

Literature: US2011/9395 A1, ; Page/Page column 12 ;

1262036-49-6

1262036-50-9

Literature: US2011/9395 A1, ; Page/Page column 33 ;